Myelodysplasia From Valproic Acid Resolved by Cessation

Chidiebube Ugwu, Angimar Uriepero Palma, Rekha Bhat, Alankrita Taneja · 2026

Read Myelodysplasia From Valproic Acid Resolved by Cessation by Chidiebube Ugwu, Angimar Uriepero Palma, Rekha Bhat, Alankrita Taneja (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13473839.txt.

Description

Myelodysplastic neoplasms (MDS) are clonal blood disorders that cause ineffective hematopoiesis, low blood counts, and a risk of progression to acute myeloid leukemia. Chemotherapy and radiation usually drive these changes, but a small set of medications, including valproic acid (VPA), can also produce reversible myelodysplastic features.

Catalog record

CREATORChidiebube Ugwu, Angimar Uriepero Palma, Rekha Bhat, Alankrita Taneja
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE16 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13473839

Browse the full library · About the Tower of Babel